Although upregulation of hepatic PPARγ has been observed in mice with hepatic steatosis, previous studies using genetically modified mouse models identified the different roles of PPARγ in hepatocytes and non-liver parenchymal cells, indicating the complicated mechanism of hepatic lipogenesis mediated by PPARγ in the liver [45]. This evidence concerns the gene PPARG and fatty liver disease.